Lung Cancer Trials Ask AI to find trials
Active Not RecruitingNot applicableNCT05747443
Official study title

Multilevel Interventions to Increase Adherence to Lung Cancer Screening

Study summary

Screening for lung cancer has the potential for a profound public health benefit. Repeat annual screening is necessary for early detection of lung cancer. The investigators will test two interventions which include patient education and reminders to improve adherence to lung cancer screening.

Ask AI to explain this study
Start here

Key things to know

Main goalHealth Services Research

This describes the study’s primary purpose.

What is being studiedStepped Reminders and Patient Education

The study team can explain what participation involves.

Who it may be forLung Cancer · Lung Cancer Screening

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Dec 24, 2025 · Source: ClinicalTrials.gov

Is enrollment open?Active Not Recruiting

The study is underway but is not accepting new participants.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Kaiser Permanente

Study sponsor

01
Study overview

What this study is about

Purpose
Health Services Research
Study type
Interventional
Phase
Not applicable
Sponsor
Kaiser Permanente
Interventions being studied
Other: Stepped Reminders; Other: Patient Education
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • KPWA members
  • Aged 50-78 years
  • Have a negative screening LDCT scan
  • Speak English or Spanish
  • Meet US Preventive Services Task Force guidelines
Reasons someone may not be able to joinExclusion criteria
  • Patients who were previously diagnosed with lung cancer,
  • Patients who have a positive scan,
  • Patients who have an indicator for interpreter services, except for Spanish

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Kaiser PermanenteSeattle, Washington

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Dec 24, 2025. Always confirm current availability with the study team.

View original record ↗